TCL Archive In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent November 27, 1987
TCL Archive New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial May 30, 2014
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
